1. Home
  2. PLUR vs NTWK Comparison

PLUR vs NTWK Comparison

Compare PLUR & NTWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLUR
  • NTWK
  • Stock Information
  • Founded
  • PLUR 2001
  • NTWK 1997
  • Country
  • PLUR Israel
  • NTWK United States
  • Employees
  • PLUR N/A
  • NTWK N/A
  • Industry
  • PLUR Biotechnology: Biological Products (No Diagnostic Substances)
  • NTWK Computer Software: Prepackaged Software
  • Sector
  • PLUR Health Care
  • NTWK Technology
  • Exchange
  • PLUR Nasdaq
  • NTWK Nasdaq
  • Market Cap
  • PLUR 36.9M
  • NTWK 34.9M
  • IPO Year
  • PLUR N/A
  • NTWK 1998
  • Fundamental
  • Price
  • PLUR $3.95
  • NTWK $3.00
  • Analyst Decision
  • PLUR Strong Buy
  • NTWK
  • Analyst Count
  • PLUR 1
  • NTWK 0
  • Target Price
  • PLUR $12.00
  • NTWK N/A
  • AVG Volume (30 Days)
  • PLUR 52.1K
  • NTWK 101.5K
  • Earning Date
  • PLUR 11-12-2025
  • NTWK 11-12-2025
  • Dividend Yield
  • PLUR N/A
  • NTWK N/A
  • EPS Growth
  • PLUR N/A
  • NTWK N/A
  • EPS
  • PLUR N/A
  • NTWK 0.04
  • Revenue
  • PLUR $1,326,000.00
  • NTWK $66,501,654.00
  • Revenue This Year
  • PLUR $97.38
  • NTWK N/A
  • Revenue Next Year
  • PLUR $293.97
  • NTWK N/A
  • P/E Ratio
  • PLUR N/A
  • NTWK $73.68
  • Revenue Growth
  • PLUR 121.74
  • NTWK 7.70
  • 52 Week Low
  • PLUR $3.22
  • NTWK $2.14
  • 52 Week High
  • PLUR $7.13
  • NTWK $5.75
  • Technical
  • Relative Strength Index (RSI)
  • PLUR 48.02
  • NTWK 30.13
  • Support Level
  • PLUR $3.50
  • NTWK $2.80
  • Resistance Level
  • PLUR $4.12
  • NTWK $3.04
  • Average True Range (ATR)
  • PLUR 0.37
  • NTWK 0.23
  • MACD
  • PLUR 0.03
  • NTWK -0.07
  • Stochastic Oscillator
  • PLUR 36.83
  • NTWK 16.56

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

About NTWK NetSol Technologies Inc. Common Stock

NETSOL Technologies Inc is an information technology and enterprise software solutions provider to original equipment manufacturers (OEMs), dealerships, and financial institutions to sell, finance, and lease assets. The firm's products include Transcend Retail, Transcend Finance, Transcend Marketplace, Transcend Consultancy, and Transcend AI Labs, catering to its customers in the different stages of how assets are sold, financed, and leased. Its primary sources of revenue are licensing, subscriptions, modification, enhancement, and support of its suite of financial applications offered to businesses in the finance and leasing space, as well as automotive digital retail. The company has three reportable segments: Asia-Pacific, its key revenue-generating market, North America, and Europe.

Share on Social Networks: